Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website
Financial release accessible online
Get Alerts HAE Hot Sheet
Join SI Premium – FREE
BRAINTREE, Mass., May 7, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year ended March 30, 2019 are available on its Investor relations website.

The Company is posting the earnings release and results tables that will be referenced on its webcast to its Investor Relations website.
Direct link to Earnings Release 4Q and FY19:
Direct link to Results Tables 4Q and FY19 That Will Be Referenced on Webcast:
As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on May 7, 2019. The call can be accessed with the following information:
- U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
- Conference ID required for access: 4378487
- A live webcast of the call can be accessed on Haemonetics' investor relations website.
- Direct link to Conference Call Webcast: https://edge.media-server.com/m6/p/299h3spu
ABOUT HAEMONETICSHaemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
Investor Contacts | Media Contact |
Gerry Gould, VP-Investor Relations | Carla Burigatto, VP-Communications |
(781) 356-9402 | (781) 348-7263 |
Olga Vlasova, Sr. Mgr.-Investor Relations | |
(781) 356 9763 | |
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-4th-quarter-and-fiscal-2019-earnings-release-available-on-investor-relations-website-300844455.html
SOURCE Haemonetics Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
- Syensqo SA (SYENS:BB) PT Raised to EUR74 at Deutsche Bank
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share